Search

Your search keyword '"E, Galdiero"' showing total 122 results

Search Constraints

Start Over You searched for: Author "E, Galdiero" Remove constraint Author: "E, Galdiero"
122 results on '"E, Galdiero"'

Search Results

1. LANTHANIDES EFFECTS ACROSS Daphnia magna GENERATIONS

2. Metallic nanoparticles: antibacterial activity and ecotoxicity

3. Novel peptide biomaterials against biofilms

7. Candida spp. morphotype differentiation on Sabouraud-Triphenyltetrazolium-Agar (STTZ-Agar) under three different experimental conditions

10. HSP and apoptosis in leukocytes from infected or vaccinated animals by Brucella abortus

11. Cytotoxic activity and IL-1 production in mice infected with Aspergillus niger

12. The effect of clindamycin on human monocytes

13. Protection of Escherichia coli K12 structural integrity by Ca2+ and Mg2+ in bactericidal and bacteriolytic tests

14. Adherence of bacteria to cardiac valve prostheses

17. The effect of dietary lipid manipulation on murine splenic lymphocytes apoptosis and heat shock protein over expression

18. Ecotoxicological and metabolomic investigation of chronic exposure of Daphnia magna (Straus, 1820) to yttrium environmental concentrations.

19. Ecotoxicity and Mutagenicity Assessment of Novel Antifungal Agents VT-1161 and T-2307.

20. A metabolomics footprinting approach using GC-MS to study inhibitory effects of the fungal metabolite diplopyrone C against nosocomial pathogen biofilms.

21. Evaluation of Potential Probiotic Properties and In Vivo Safety of Lactic Acid Bacteria and Yeast Strains Isolated from Traditional Home-Made Kefir.

22. A Preliminary Evaluation on the Antifungal Efficacy of VT-1161 against Persister Candida albicans Cells in Vulvovaginal Candidiasis.

23. Extracellular Vesicles from a Biofilm of a Clinical Isolate of Candida albicans Negatively Impact on Klebsiella pneumoniae Adherence and Biofilm Formation.

24. Polystyrene Microplastics Exacerbate Candida albicans Infection Ability In Vitro and In Vivo.

25. Multigenerational tests on Daphnia spp.: a vision and new perspectives.

26. A Re-Purposing Strategy: Sub-Lethal Concentrations of an Eicosanoid Derived from the Omega-3-Polyunsaturated Fatty Acid Resolvin D1 Affect Dual Species Biofilms.

27. Candida Biofilm Eye Infection: Main Aspects and Advance in Novel Agents as Potential Source of Treatment.

28. Effect of Escin Alone or in Combination with Antifungal Agents on Resistant Candida glabrata Biofilms: Mechanisms of Action.

29. Prevalence, Resistance Patterns and Biofilm Production Ability of Bacterial Uropathogens from Cases of Community-Acquired Urinary Tract Infections in South Italy.

30. Synthesis of temporin L hydroxamate-based peptides and evaluation of their coordination properties with iron(III ).

31. Anti-Biofilm Activity of Phenyllactic Acid against Clinical Isolates of Fluconazole-Resistant Candida albicans .

32. Myxinidin-Derived Peptide against Biofilms Caused by Cystic Fibrosis Emerging Pathogens.

33. VT-1161-A Tetrazole for Management of Mono- and Dual-Species Biofilms.

34. The Arylamidine T-2307 as a Novel Treatment for the Prevention and Eradication of Candida tropicalis Biofilms.

35. A model for microbial interactions and metabolomic alterations in Candida glabrata-Staphylococcus epidermidis dual-species biofilms.

36. Undesired Effect of Vancomycin Prolonged Treatment: Enhanced Biofilm Production of the Nosocomial Pathogen Candida auris .

37. Effect of Myrtenol and Its Synergistic Interactions with Antimicrobial Drugs in the Inhibition of Single and Mixed Biofilms of Candida auris and Klebsiella pneumoniae .

38. Competitiveness during Dual-Species Biofilm Formation of Fusarium oxysporum and Candida albicans and a Novel Treatment Strategy.

39. Hygienic assessment of digestate from a high solids anaerobic co-digestion of sewage sludge with biowaste by testing Salmonella Typhimurium, Escherichia coli and SARS-CoV-2.

40. Evaluation of the Pathogenic-Mixed Biofilm Formation of Pseudomonas aeruginosa / Staphylococcus aureus and Treatment with Limonene on Three Different Materials by a Dynamic Model.

41. Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species.

42. WMR Peptide as Antifungal and Antibiofilm against Albicans and Non-Albicans Candida Species: Shreds of Evidence on the Mechanism of Action.

43. Activity of Free and Liposome-Encapsulated Essential Oil from Lavandula angustifolia against Persister-Derived Biofilm of Candida auris .

44. Comparative Toxicological Evaluation of Tattoo Inks on Two Model Organisms.

45. Ecotoxicity and photodegradation of Montelukast (a drug to treat asthma) in water.

46. Pentadecanoic acid against Candida albicans-Klebsiella pneumoniae biofilm: towards the development of an anti-biofilm coating to prevent polymicrobial infections.

47. Long-term multi-endpoint exposure of the microalga Raphidocelis subcapitata to lanthanum and cerium.

48. An Integrated Analysis of Intracellular Metabolites and Virulence Gene Expression during Biofilm Development of a Clinical Isolate of Candida tropicalis on Distinct Surfaces.

49. Screening and isolation of microbes from a Mud Community of Ischia Island Thermal Springs: preliminary analysis of a bioactive compound.

50. GC-MS-Based Metabolomics Study of Single- and Dual-Species Biofilms of Candida albicans and Klebsiella pneumoniae .

Catalog

Books, media, physical & digital resources